Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5539 studies found for:    lymphoma
Show Display Options
Rank Status Study
1 Completed An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Condition: Lymphoma
Intervention: Other: No intervention
2 Recruiting Brazilian Network for Lymphoma Registry
Condition: Lymphoma
Intervention: Other: Observational, non-intervention
3 Recruiting Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma
Conditions: Lymphoma;   Lymphoplasmacytic Lymphoma;   Waldenström Macroglobulinemia
Intervention: Biological: DNA Vaccine
4 Active, not recruiting Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Biological: Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
5 Completed Samsung Medical Center-Lymphoma Cohort Study
Condition: Lymphoma
Intervention: Drug: Chemotherapy with or without radiotherapy
6 Recruiting MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
Condition: Lymphoma
Interventions: Device: magnetic resonance imaging;   Device: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
7 Withdrawn Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma;   Lymphoma
Intervention: Procedure: PET/CT Scanning
8 Completed Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Condition: Lymphoma
Interventions: Drug: BIAXIN (CLARITHROMYCIN);   Drug: Biaxin (clarithromycin)
9 Recruiting Clinical Cohort of Lymphoma Patients in Malawi
Conditions: Lymphoma;   Hematologic Malignancies
Intervention:
10 Unknown  Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention:
11 Completed Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cytarabine;   Drug: etoposide phosphate;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide
12 Recruiting Idiotypic Vaccination for Follicular Lymphoma Patients
Conditions: Follicular Lymphoma;   First Relapse/Progression
Intervention: Biological: Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
13 Recruiting Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
Condition: Lymphoblastic Lymphoma
Intervention: Other: Latest generation chemotherapies for T-LBL + transplant
14 Enrolling by invitation Lymphoma in the Orbit
Condition: Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
Intervention: Procedure: Lymphoma-Biopsy
15 Unknown  Samsung Medical Center-Lymphoma Cohort Study-II
Condition: Lymphoma
Intervention:
16 Completed Velcade in MALT Lymphoma Patients
Condition: MALT Lymphoma
Intervention: Drug: Bortezomib (Velcade)
17 Unknown  Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
Conditions: HIV;   Lymphoma
Intervention:
18 Completed Lymphoma Follow-up
Condition: Lymphoma
Intervention:
19 Withdrawn Molecular Epidemiology of Lymphoma Patients
Condition: Lymphoma
Intervention: Behavioral: Questionnaire
20 Completed Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma
Intervention: Drug: bendamustine hydrochloride

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.